Citations

Clear

6273 citation(s) found for "To, Andrew".

Facial Anatomy Teaching for Aesthetic Surgery: Using 3-dimensional Photogrammetry and Immersive Virtual Reality
Hussein, Sara , Emanuels, Andrew F., Leonel, Luciano, Lachman, Nirusha , Celda, María Peris, Sheahan, Eric M., Martinez, Erick O., Leonel, Luciano César P C, Peris Celda, Maria, Hanson, Christian R., Emanuels, Andrew, Morris, Jonathan M. , Martinez, Erick O., Hanson, Christian R., Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | July 9, 2025 | Volume: 13 | Issue: 7 | Pages: e6972

10.1097/gox.0000000000006972 | PMID 40642258 Get It

Summary: Anatomy is a critical component of surgical training; however, traditional resources—such as Netter’s Surgical Anatomy , Gray’s Anatomy , and anatomy applications—often fall short in delivering surgically relevant, 3-dimensional (3D) perspectives of facial anatomy. Although cadaveric dissection remains a valuable teaching tool, its accessibility is limited by cost, ethical concerns, and the lack of structured curricula, making it less feasible for ongoing surgical education. To address these limitations, this article introduced a novel educational approach that integrates 3D photogrammetry and virtual reality technology into the surgical anatomy curriculum for craniofacial and aesthetic surgery. Six fresh cadaveric specimens were meticulously dissected by a plastic surgeon to illustrate the intricate layered anatomy of the face and neck. At each stage of the dissection, a photogrammetry technique was used to capture 360-degree images using 5 digital single-lens reflex cameras alongside a 3D handheld camera. This approach not only ensured high-quality imaging but also facilitated the creation of detailed, lifelike virtual 3D models, enhancing the understanding of facial and neck anatomy within a surgical context. Additionally, we present some technical refinements of the 3D volume renderings to capture precise anatomical details during our dissections. Preliminary results from the use of this technology in anatomy courses and workshops indicated trainee engagement, a clearer grasp of the spatial anatomical relationships, and greater confidence in applying this knowledge to hands-on surgical procedures.
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Razzo, Beatrice M. , Midha, Shonali , Portuguese, Andrew J. , Grajales‐Cruz, Ariel , Corraes, Andre De Menezes Silva , Costello, Patrick , Liu, Yuxin , Sperling, Adam S. , Nadeem, Omar , Dima, Danai , Cowan, Andrew J. , Afrough, Aimaz , Anderson, Larry D. , Goyal, Anmol , Ferreri, Christopher J. , Voorhees, Peter M. , Patel, Krina K. , Julian, Kelley , Forsberg, Peter A. , Susanibar-Adaniya, Sandra P. , Khouri, Jack , Raza, Shahzad , Vazquez‐Martinez, Mariola , Sborov, Douglas W. , Davis, James A. , Shune, Leyla , Bhurtel, Jenny , Hwang, Wei‐Ting , Sidana, Surbhi , Grajales-Cruz, Ariel F , De Menezes Silva Corraes, Andre , Banerjee, Rahul , Cowan, Andrew J , Afrough, Aimaz , Anderson, Larry D , Lieberman-Cribbin, Alex , Kaur, Gurbakhash , Goyal, Anmol , Atrash, Shebli , Ferreri, Christopher , Voorhees, Peter , Pasvolsky, Oren , Lee, Hans C , Patel, Krina , Julian, Kelley L , Forsberg, Peter A , Herr, Megan M. , Chhabra, Saurabh , Parrondo, Ricardo D , Lin, Yi , Chen, Anna , Susanibar-Adaniya, Sandra P , Khouri, Jack , Raza, Shahzad , Anwer, Faiz , Vazquez-Martinez, Mariola A , Castaneda Puglianini, Omar , Sborov, Douglas W , Davis, James A , Rossi, Adriana , Shune, Leyla , Bhurtel, Evguenia , Hwang, Wei-Ting , Hansen, Doris K , Sidana, Surbhi , Garfall, Alfred L , Richard, Shambavi , Nadeem, Omar , Dima, Danai , Sperling, Adam S , Portuguese, Andrew J , Banerjee, Rahul , Kaur, Gurbakhash , Atrash, Shebli , Pasvolsky, Oren , Lee, Hans C. , Chhabra, Saurabh , Lin, Yi , Anwer, Faiz , Puglianini, Omar Castañeda , Rossi, Adriana , Hansen, Doris K. , Garfall, Alfred L. , Richard, Shambavi

Mayo Clinic

Blood Cancer Discovery | July 9, 2025 | Volume: 6 | Issue: 6 | Pages: 561-571

10.1158/2643-3230.bcd-24-0354 | PMID 40629516 Get It

Abstract Teclistamab is an anti-CD3-/B-cell maturation antigen (BCMA) bispecific antibody approved for use in relapsed/refractory multiple myeloma. We undertook a retrospective study of post-approval, real-world outcomes with teclistamab in the US Multiple Myeloma Immunotherapy Consortium. Among 509 patients, 89% would have been ineligible for the MajesTEC-1 trial, primarily due to prior BCMA-directed therapy, cytopenias, or diminished performance status. Cytokine release syndrome occurred in 54% (1.4% grade ≥3) and immune effector cell–associated neurotoxicity syndrome in 11% (2.2% grade ≥3), with no fatal events. Infections occurred in 42% and contributed to death in 5%. Partial response (PR) or better was achieved in 53% and very good PR or better in 45%. With 10.1 months of median follow-up, the estimated median progression-free survival (PFS) was 5.8 months and 12-month overall survival was 61%. Independent predictors of less than very good PR and shorter PFS included BCMA-directed chimeric antigen receptor T-cell therapy in the previous 9 months, high disease burden, lymphopenia, and elevated ferritin. Significance: T cell–engaging bispecific antibodies such as teclistamab represent an important new treatment modality for multiple myeloma and other blood cancers. This study evaluates the real-world safety and efficacy of teclistamab, including its activity in populations not represented in the initial phase I/II study, and identifies clinical variables associated with treatment response. See related commentary by Zweegman et al., p. 542
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry
Jose, Arun , Yogeswaran, Athiththan , Fünderich, Meike , Kiely, David G. , Sweatt, Andrew J. , Zamanian, Roham T. , Mouawad, Antoine , Balasubramanian, Aparna , Wilkins, Martin R. , Olschewski, Horst , Eichstaedt, Christina A. , Sіrenko, Yu.M. , Majeed, Raphael W. , Wilhelm, Jochen , Tello, Khodr , Elwing, Jean , Seeger, Werner , Thenappan, Thenappan , Ghouleh, Imad Al , Fuenderich, Meike , Kiely, David , Mouawad, Antoine , Wilkins, Martin , Sahay, Sandeep , Giannakoulas, George , Cajigas, Héctor , Frantz, Robert P , Ghio, Stefano , Majeed, Raphael W , Tello, Khodr , Elwing, Jean M , Seeger, Werner , Olschewski, Horst , Thenappan, Thenappan , Jose, Arun , Yogeswaran, Athiththan , Balasubramanian, Aparna , Hassoun, Paul M. , Lawrie, Allan , Howard, Luke , Sahay, Sandeep , Kovács, Gábor , Saleh, Khaled Musa Mohammad , Sabbour, Hani Mohamed , Grünig, Ekkehard , Arvanitaki, Alexandra , Torbas, O.O. , Frantz, Robert P. , Scelsi, Laura , Ghio, Stefano , Ghofrani, Hossein Ardeschir , Grimminger, Friedrich

Mayo Clinic

Pulmonary Circulation | July 9, 2025 | Volume: 15 | Issue: 3 | Pages: No page available

10.1002/pul2.70121 | PMID 40636151 Get It

ABSTRACTPortopulmonary hypertension (PoPH), a type of pulmonary arterial hypertension (PAH) in patients with liver disease, is associated with high morbidity and mortality. The relationship between cardiopulmonary hemodynamics, PAH therapy, and survival in PoPH remains unclear. We performed a retrospective cohort study of PoPH patients from the international pulmonary hypertension (PH) meta‐registry, PVRI GoDeep. PAH was defined by a mean pulmonary arterial pressure > 20 mmHg, pulmonary arterial wedge pressure ≤ 15 mmHg, and a pulmonary vascular resistance (PVR) > 2 Wood Units. PoPH diagnoses were assigned by each center's PH specialist based on international guidelines at the time of enrollment. 246 incident PoPH patients met eligibility criteria and were included in the analysis, equally split between males (51%) and females (49%), with a median age of 54 years. When compared to both patients with IPAH and those with other subtypes of PAH (not classified as PoPH or IPAH), those with PoPH had significantly lower 5‐year survival rates (46% vs. 68% vs. 65%, log‐rank p < 0.001). Amongst the PoPH patients, however, there was no significant difference in 5‐year survival when dichotomized by disease severity, either by a PVR of 5 Wood Units or a CI of 2.5 L/min/m2. Treatment of the PoPH patients with PAH‐targeted therapies was associated with significantly higher 5‐year survival rates compared to those not receiving such treatments, as shown by Kaplan–Meier analysis. This survival benefit was observed for PDE5i (50% vs. 34%, log‐rank p = 0.029), ERA (58% vs. 34%, log‐rank p < 0.001), and the combination of PDE5i and/or ERA (51% vs. 22%, log‐rank p < 0.001), as well as any PAH‐targeting treatment (50% vs. 26%, log‐rank p = 0.007). Corresponding survival advantage was noted when including only PoPH patients with MELD Score ≥ 13. PoPH is a disease with significantly worse long‐term survival than other PAH subtypes, but targeted PAH therapy is associated with a robust survival benefit. Survival did not differ across high‐risk PVR and cardiac index thresholds, suggesting the factors that influence prognosis and survival in PoPH may be unique as compared to other PAH subtypes, and warrant further investigation.
Bilateral Kienböck Disease: Associations With Demographic, Systemic, and Radiologic Findings
Emanuels, Andrew, Rames, Jess D. , Tunaboylu, Mehmet Furkan , Moran, Steve, Emanuels, Andrew F., Rames, Jess, Moran, Steven L

Mayo Clinic

HAND | July 8, 2025 | Volume: 21 | Issue: 5 | Pages: 772-777

10.1177/15589447251350174 | PMID 40624876 Get It

Background: Kienböck disease most frequently affects 1 wrist and rarely occurs bilaterally. The purpose of this study is to describe the natural history and identify risk factors for development of bilateral Kienböck disease. Methods: After institutional review board approval, 350 patients with surgically managed Kienböck disease from 1976 to 2023 were identified. A retrospective review of the electronic medical record was used to collect demographic, clinical, and radiographic information. Two-tailed student t -test was used for continuous variable, and Fisher’s exact test was used for categorical variables with analysis of power. Results: Ten of 350 patients (2.9%) had bilateral disease. The mean age was 45 (range: 14-62) years, and 6 out of 10 patients were female. The mean follow-up time was 47 (range: 9-274) months. Three of the 10 patients were laborers. Antecedent trauma (n = 2), prior corticosteroid injection (n = 1), and concomitant autoimmune disease (n = 1) were rare events. There was no difference in Lichtman Stage comparing the dominant and nondominant hands, and 72.2% of wrists were ulnar negative. This was higher but not significantly different than the unilateral affected comparison cohort (60%). Sufficient power was demonstrated (0.99). Eighteen of 20 wrists were treated operatively. Two cases required operative revision due to progression of disease. Conclusions: The cause of bilateral versus unilateral Kienböck disease remains unclear. Bilateral disease was not associated with a higher incidence of autoimmune disease, systemic corticosteroid use, or exposure to heavy manual labor. However, thrombosis leading to avascular necrosis of the lunate may be influenced by hypercoagulable and inflammatory diseases. Surgeons should maintain a high index of suspicion for bilateral disease in patients with these comorbidities. Routine screening of the contralateral wrist is unjustified if the patient is asymptomatic.
Multicenter validation of a cholangioscopy artificial intelligence system for the evaluation of biliary tract disease
Marya, Neil B. , Powers, Patrick, Marcello, Matthew, Nasser‐Ghodsi, Navine , Rau, Prashanth , Mehta, Savant, Marshall, Christopher J., Leonor, Paul , Che, Kendrick , Petersen, Bret T. , Law, Ryan , Martin, John A. , AbiMansour, Jad P. , Abu Dayyeh, Barham, Storm, Andrew C , Vargas, Eric J , Marya, Neil B. , Thiruvengadam, Nikhil Ravi , Zivny, Jaroslav, Marshall, Christopher, Dayyeh, Barham K. Abu , Storm, Andrew C. , Petersen, Bret T. , Vargas, Eric J. , Chandrasekhara, Vinay

Mayo Clinic

Endoscopy | July 6, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2650-0789 | PMID 40618756 Get It

Abstract Clinicians struggle to accurately classify biliary strictures as benign or malignant. Current endoscopic retrograde cholangiopancreatography (ERCP)-based sampling modalities including brush cytology and forceps biopsy have poor sensitivity for pathologic confirmation of malignancy. Cholangioscopy allows for direct visualization and sampling of biliary pathology; however, this technology is also associated with inaccurate classification of biliary disease. Previously, an artificial intelligence (AI) system that analyzes cholangioscopy footage was found to be more accurate in diagnosing biliary malignancy than ERCP sampling techniques. The aim of this study was to validate this AI system on a new series of examinations. Three academic centers collected all available unedited cholangioscopy recordings. The videos were processed by the cholangioscopy AI system. After analyzing videos, the AI system provided predictions as to whether malignancy was present. AI performance in classifying strictures was compared with the performance of brush cytology and forceps biopsy. 112 cholangioscopy examinations (containing 4 817 081 images) were generated from 99 patients. Of those examinations, 61 (54.5%) were for investigation of biliary strictures (31 [50.8%] benign, 30 [49.2%] malignant). For the correct classification of strictures, the AI system was 80.0% sensitive and 90.3% specific. It was also significantly more accurate for stricture classification (85.2%) than brush cytology (52.5%; P<0.001), forceps biopsy (68.2%; P=0.04), and the combination of brush cytology and forceps biopsy (66.7%; P=0.02). A previously developed cholangioscopy AI system was found to continually outperform standard ERCP sampling modalities for accurate identification of malignancy, without additional retraining, in a multicenter validation cohort.
Comparison of Digital Breast Tomosynthesis and Mammography-based Radiomics for Breast Cancer Risk Assessment: Case-Control Study
Nguyen, Alex , Cohen, Eric A. , Maghsoudi, Omid Haji , Acciavatti, Raymond J. , Pantalone, Lauren , Mankowski, Walter C. , Scott, Christopher G. , Winham, Stacey J. , Vachon, Celine M. , Maidment, Andrew D. A. , Nguyen, Alex A , Haji Maghsoudi, Omid , Winham, Stacey J , Maidment, Andrew D A , Conant, Emily F , Kontos, Despina , Scott, Christopher , Mankowski, Walter C , Acciavatti, Raymond J , Vachon, Celine M. , Conant, Emily F. , McCarthy, Anne Marie

Mayo Clinic

Radiology: Imaging Cancer | July 3, 2025 | Volume: 7 | Issue: 4 | Pages: No page available

10.1148/rycan.240318 | PMID 40607929 Get It

Three-dimensional radiomic analysis of digital breast tomosynthesis outperformed two-dimensional measures in breast cancer risk assessment.
International Delphi Consensus on Medial Meniscal Root Tears Shows High Agreement on Diagnosis, Treatment, and Rehabilitation but Lack of Agreement on Treatment of Asymptomatic Tears
Chahla, Jorge , Chahla, Jorge, García, José Rafael , Tollefson, Luke V. , Dzidzishvili, Lika , Gerhold, Cameron , Krych, Aaron J. , LaPrade, Robert F., Group, Meniscus Root International Expert, Bassett, Ashley J., Bernholt, David L., Bhatia, Sanjeev, Bøe, Berte, Brown, Charles H., Chung, Kyu Sung, Cohen, Moisés, Engebretsen, Lars, Familiari, Filippo, Faucett, Scott C., Feucht, Matthias J., Furumatsu, Takayuki, Geeslin, Andrew G., Getgood, Alan M.J., Hiranaka, Takaaki, Inderhaug, Eivind, Iñiguez, C. Magaly, Johnson, Darren L., Kim, Jin Goo, Kim, Sung‐Hwan, Kodama, Yuya, Kon, Elizaveta, Kopf, Sebastian, LaPrade, Christopher M., Larson, Christopher M., Lee, Dhong Won, Lind, Martin, Logan, Catherine A., López‐Torres, Irene I., Lording, Timothy, Maestu, Rodrigo, Moatshe, Gilbert, Monson, Jill K., Murray, Iain R., Musahl, Volker, Vyhmeister, Roberto Negrin, Okazaki, Yuki, Parker, David, Petersen, Wolf, Riboh, Jonathan C., Seil, Romain, Servien, Elvire, Sonnery‐Cottet, Bertrand, Spalding, Tim, Stevenson, Ciara, Stuart, Michael J., Tanaka, Miho J., Tapasvi, Sachin, Tuca, Maria, Wal, Wybren A. van der, Verma, Nikhil N., Bormann, Richard PB. von, Yanke, Adam B., Krych, Aaron J., Kopf, Sebastian , Krych, Aaron J , Chahla, Jorge A , Chahla, Jorge, Allende, Felicitas , LaPrade, Robert F., Group, Meniscus Root International Expert, Bassett, Ashley J., Bernholt, David L., Bhatia, Sanjeev, Bøe, Berte, Brown, Charles H., Chung, Kyu Sung, Cohen, Moisés, Engebretsen, Lars, Familiari, Filippo, Faucett, Scott C., Feucht, Matthias J., Furumatsu, Takayuki, Geeslin, Andrew G., Getgood, Alan M.J., Hiranaka, Takaaki, Inderhaug, Eivind, Iñiguez, C. Magaly, Johnson, Darren L., Kim, Jin Goo, Kim, Sung‐Hwan, Kodama, Yuya, Kon, Elizaveta , LaPrade, Christopher M., Larson, Christopher M., Lee, Dhong Won, Lind, Martin, Logan, Catherine A., López‐Torres, Irene I., Lording, Timothy, Maestu, Rodrigo, Moatshe, Gilbert, Monson, Jill K., Murray, Iain R., Musahl, Volker, Vyhmeister, Roberto Negrin, Okazaki, Yuki, Parker, David, Petersen, Wolf, Riboh, Jonathan C., Seil, Romain, Servien, Elvire, Sonnery‐Cottet, Bertrand, Spalding, Tim, Stevenson, Ciara, Stuart, Michael J., Tanaka, Miho J., Tapasvi, Sachin, Tuca, Maria, Wal, Wybren A. van der, Verma, Nikhil N., Bormann, Richard PB. von, Yanke, Adam B., Krych, Aaron J.

Mayo Clinic

Arthroscopy | July 3, 2025 | Volume: 41 | Issue: 11 | Pages: 4683-4698

10.1016/j.arthro.2025.06.028 | PMID 40614908 Get It

Purpose To develop an expert consensus statement on the diagnosis, management, and rehabilitation of medial meniscal root tears (MMRTs) using a modified Delphi technique. Methods A working group developed statements on MMRT diagnosis, nonoperative management, surgical indications, surgical management, alignment, and rehabilitation using modified Delphi techniques. Fifty‐six experts were surveyed over 3 rounds to reach consensus, with agreement measured on a 5‐point Likert scale. Statements were included, revised, or excluded on the basis of predefined thresholds (≥75% agreement, <20% disagreement). Experts suggested revisions or new statements in the first 2 rounds, and final consensus statements were included. Results All 56 experts completed 3 survey rounds. Experts agreed that root tears may occur with no known history of trauma, typically in older patients, and that it should be diagnosed with an magnetic resonance imaging. In symptomatic patients with MMRTs without advanced osteoarthritis should be repaired using an anatomic transtibial pull‐out technique (performing a pie‐crusting technique can be helpful for visualization). Nonoperative management is advised for patients with advanced osteoarthritis. High tibial osteotomy may be considered for significant varus malalignment during MMRT repair. The only statement without consensus was the management of asymptomatic MMRTs with mild medial compartment cartilage wear, indicating ongoing debate. Conclusions Overall, 98% of statements reached consensus. There is agreement that magnetic resonance imaging is the gold standard for diagnosis. Symptomatic MMRTs without advanced osteoarthritis should be repaired early using an anatomic transtibial pull‐out technique. End‐stage knee osteoarthritis warrants nonoperative management of MMRTs, and a structured postoperative protocol with limited weightbearing and range of motion is essential after repair. No agreement was reached on managing asymptomatic MMRTs in patients without significant medial compartment degeneration. Meniscal centralization sutures may help in cases of substantial extrusion, but their routine use is debated. Level of Evidence Level V, consensus of expert opinion.
Coupling of Low Frequency Hemodynamic Oscillations Between the Brain and Spinal Cord
Frels, Andrew John , Nair, Vidhya Vijayakrishnan , Kish, Brianna , Riley, Kalen , Mao, Gordon , Tong, Yunjie , Tong, Yunjie , Schwichtenberg, Amy J.

Mayo Clinic

Human Brain Mapping | July 3, 2025 | Volume: 46 | Issue: 10 | Pages: No page available

10.1002/hbm.70278 | PMID 40607866 Get It

ABSTRACTIn Functional Magnetic Resonance Imaging (fMRI), the primary contrast is Blood Oxygen Level Dependent (BOLD) signal. Systemic Low Frequency Oscillations (sLFO) are BOLD signals between 0.01 and 0.1 Hz originating from systemic physiological processes. While sLFO signals in the brain have been shown to travel with blood in numerous studies, their behavior in the spinal cord (SC) remains unexplored. This study characterizes the coupling between brain‐sLFO and SC‐sLFO signals. Understanding brain‐SC‐coupling is pivotal for unraveling the vascular continuity of the central nervous system, which plays a crucial role in SC‐injury pathophysiology. BOLD signal extraction involved registering structural masks to fMRI space to obtain average time series from the brain, SC, and superior sagittal sinus. The sLFOs of the time series were cross‐correlated to determine vascular delays and analyzed for band power. It is found that the SC‐sLFO signal comprises two components relative to the brain, showing opposite correlation polarity and varying delays. These findings suggest that highly oxygenated blood arrives at the spinal cord before arriving at the brain, and some component of the brain's venous output circulates to or near to the spinal cord later, likely due to unique arterial and venous pathways connecting the central nervous system. This insight offers a valuable imaging marker for future studies on the effects of SC injury on brain‐SC interconnectivity.
Pneumocystis Pneumonia in Cirrhosis: An Underrecognized Fungal Infection in a Vulnerable Host
Pulsipher, Aaron M. , Barnhill, Michele , Vikram, Holenarasipur R. , Gotway, Michael B. , Cartin‐Ceba, Rodrigo , Zhou, Kevin , Thompson, Emily , Aqel, Bashar , Ham, Kealy R., Thompson, Emily R , Aqel, Bashar A. , Ham, Kealy , Vikram, Holenarasipur R. , Gotway, Michael B , Pulsipher, Aaron M , Limper, Andrew H.

Mayo Clinic

Journal of Fungi | July 3, 2025 | Volume: 11 | Issue: 7 | Pages: 500

10.3390/jof11070500 | PMID 40985382 Get It

Pneumocystis pneumonia (PCP) is a serious fungal infection affecting immunocompromised hosts. Decompensated cirrhosis leads to cirrhosis-associated immune dysfunction (CAID), a form of impaired cellular immunity that may predispose patients to opportunistic infections such as PCP. We conducted a retrospective review of 727 patients with proven or probable PCP from 2017 to 2025. Of these, 33 had decompensated cirrhosis. These patients were stratified into two groups: Cirrhosis Only (n = 16) and Cirrhosis with Additional Immunocompromising Conditions (n = 17). Among the patients with cirrhosis, the overall mortality was 48%, with the 90-day mortality reaching 57.6% (95% CI: 39.2–74.5%). Compared with those without cirrhosis, the patients with cirrhosis had a higher risk of mortality (OR: 4.08, 95% CI: 2.01–8.30, p < 0.001), increased intensive care unit (ICU) admission (87% vs. 42%, p < 0.001), and greater need for renal replacement therapy (54.6% vs. 7.5%, p < 0.001). These findings suggest that decompensated cirrhosis alone may represent a sufficient and underrecognized risk factor for PCP, with a high associated mortality. Given the preventable nature of this infection, future studies are needed to assess the incidence, define the risk, and investigate the role of prophylaxis in this vulnerable population.
Emerging Trends in Endoscopic Bariatric Therapies: Personalization Through Genomics and Synergistic Pharmacotherapy
Ghusn, Wissam , Divakar, Annika, Abi Mosleh, Kamal , Ghusn, Wissam , Divakar, Annika, Salameh, Yara , Mosleh, Kamal Abi , Storm, Andrew C.

Mayo Clinic

Journal of Clinical Medicine | July 2, 2025 | Volume: 14 | Issue: 13 | Pages: 4681

10.3390/jcm14134681 | PMID 40649055 Get It

Obesity is a major global health challenge associated with significant metabolic and gastrointestinal comorbidities. While metabolic and bariatric surgery remains the gold standard for durable weight loss, the desire for additional options has fueled the development of endoscopic bariatric therapies (EBTs) as another tool for weight loss. This review examines established EBTs, including endoscopic sleeve gastroplasty (ESG), intragastric balloons (IGBs), and transoral outlet reduction (TORe), alongside emerging therapies such as duodenal mucosal resurfacing (DMR), incisionless anastomosis creation, and fully automated endoscopic gastric remodeling systems. ESG has demonstrated durable weight loss, favorable safety, and superior cost-effectiveness compared to pharmacotherapy alone, while combination strategies using EBTs and anti-obesity medications (AOMs), particularly GLP-1 receptor agonists, have resulted in greater total-body weight loss than either modality alone. Genetic variation, particularly within the leptin–melanocortin pathway, may predict response to endoscopic interventions and guide personalized treatment selection. Novel investigational procedures such as DMR, automated or robotic gastric remodeling, and magnetic or ultrasound-assisted gastric bypass show promising early results. Endoscopic therapies are poised to become increasingly central to the personalized, scalable management of obesity and related metabolic diseases.